W
Werner Hacke
Researcher at Heidelberg University
Publications - 688
Citations - 93115
Werner Hacke is an academic researcher from Heidelberg University. The author has contributed to research in topics: Stroke & Thrombolysis. The author has an hindex of 123, co-authored 656 publications receiving 84593 citations. Previous affiliations of Werner Hacke include University Hospital Heidelberg & Steklov Mathematical Institute.
Papers
More filters
Journal ArticleDOI
Interleukin-2, its soluble receptor, and soluble T8 antigen in acute ischemic stroke.
TL;DR: Results reflect an immunological response to the cerebral infarct and do not indicate a general role of the IL‐2 system in the pathogenesis of ischemic stroke with or without previous infection.
Book ChapterDOI
General Assessment and Care of the New Patient
TL;DR: Patients should receive neurocritical care if they have signs of increased intracranial pressure, coma, or neurological disease associated with respiratory or cardiovascular failure, and those receiving thrombolytic therapy and plasmapheresis or those undergoing interventional neuroradiological procedures may also benefit from neuro critical care (high- or low-acuity monitoring.
Journal ArticleDOI
The Surviral Epidemiological Early Warning System Tyrol Dashboard - System, Functionality and Findings
TL;DR: In this article , the authors present the Surviral dashboard, which allows the effective monitoring of infectious disease dynamics and provides a convenient and efficient way to monitor the spread of a disease and identify potential areas for intervention.
Journal ArticleDOI
Systemische Thrombolysetherapie des akuten Hirninfarkts: Zehn Jahre Erfahrungen aus einem überregionalen Schlaganfallzentrum
TL;DR: In this paper, the authors report on the changes in this patient population from 1996 to 2006, with special consideration of those suitable for intravenous thrombolysis, and show that the proportion of stroke patients admitted within the first 3 hours after symptom onset increased from 12.1% (1996) to 21.9% (2006).
Journal ArticleDOI
Oral anticoagulation across diabetic subtypes in patients with newly diagnosed atrial fibrillation: A report from the GARFIELD-AF registry.
Jean-Pierre Bassand,Saverio Virdone,A. John Camm,Keith A.A. Fox,Samuel Z. Goldhaber,Shinya Goto,Sylvia Haas,Werner Hacke,Gloria Kayani,Matyas Keltai,Frank Misselwitz,Karen S. Pieper,Alexander G.G. Turpie,Freek W.A. Verheugt,Ajay K. Kakkar +14 more
TL;DR: In this paper , the authors describe both management and prognosis of patients with diabetes mellitus (DM) and newly diagnosed atrial fibrillation (AF), overall as well as by antidiabetic treatment, and assess the influence of oral anticoagulation (OAC) on outcomes by DM status.